Target Ability

Discover LYMPHOSEEK®, the only agent designed and FDA-approved for lymphatic mapping in patients with solid tumors for which this procedure is a component of intraoperative management; guiding sentinel lymph node biopsy in patients with breast cancer, melanoma, and squamous cell carcinoma of the oral cavity; and use with scintigraphic imaging.

Click to watch LYMPHOSEEK in action